Pharmarise Holdings Corporation

Tokyo Stock Exchange 2796.T

Pharmarise Holdings Corporation Dividend Yield on February 07, 2025: 2.23%

Pharmarise Holdings Corporation Dividend Yield is 2.23% on February 07, 2025, a 20.50% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Pharmarise Holdings Corporation 52-week high Dividend Yield is 2.31% on January 09, 2025, which is 3.55% above the current Dividend Yield.
  • Pharmarise Holdings Corporation 52-week low Dividend Yield is 1.61% on October 01, 2024, which is -27.56% below the current Dividend Yield.
  • Pharmarise Holdings Corporation average Dividend Yield for the last 52 weeks is 1.84%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 2796.T

Pharmarise Holdings Corporation

CEO Mr. Masayuki Akiyama
IPO Date Feb. 21, 2007
Location Japan
Headquarters Sumitomo Nakano Sakue Building
Employees 1,848
Sector Healthcare
Industries
Description

Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores; and sells cosmetics. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; operation of medical mall; and provision of temporary help. As of May 31, 2021, the company operated 347 stores. Pharmarise Holdings Corporation was incorporated in 1984 and is headquartered in Tokyo, Japan.

Similar companies

3439.T

Mitsuchi Corporation

USD 4.25

-3.93%

2798.T

Y's Table Corporation

USD 19.39

-0.92%

3524.T

Nitto Seimo Co., Ltd.

USD 10.56

-0.45%

3173.T

Cominix Co.,Ltd.

USD 5.96

0.27%

3353.T

Medical Ikkou Group Co.,Ltd.

USD 14.53

1.80%

StockViz Staff

February 8, 2025

Any question? Send us an email